Results 41 to 50 of about 911,595 (287)

Diagnostic Value of Combined: C- Reactive Protein, Total Leukocyte Count and Platelet Count in Neonatal Sepsis [PDF]

open access: yes, 2016
Objective: This study was designed to evaluate the diagnostic value of combination of Total Leukocyte Count, Platelet count and C - reactive protein for the diagnosis of neonatal sepsis.
Hussain Sherazi, Sajid   +1 more
core   +2 more sources

Diagnostic Value of C-Reactive Protein and Total Leukocyte Count in Acute Appendicitis

open access: yesPakistan Armed Forces Medical Journal
Objective: To find the diagnostic value of C-Reactive Protein and Total Leukocyte Count in acute appendicitis. Study Design: Validation study. Place and Duration of Study: Department of Surgery, Combined Military Hospital, Bahawalpur Pakistan, from ...
Erisha Komal   +4 more
doaj   +1 more source

Association of nutritional anemia with leukocyte and platelet counts in people of Odisha

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2018
Background: Anemia is the most common hematological disorder in the world, due to deficiency of micronutrients such as iron, Zn, Se, Cu, folic acid, and vitamins. Iron deficiency impairs immune response and bactericidal activity of macrophages, monocytes,
Priyadarsini Samanta   +1 more
doaj   +1 more source

Platelet count, Leukocyte count and mtDNAcn(WB) distributions in all subjects from the AWHS cohort study (n = 3389).

open access: yes, 2016
Platelet count, Leukocyte count and mtDNAcn(WB) distributions in all subjects from the AWHS cohort study (n = 3389).
Raquel Moreno-Loshuertos (223777)   +6 more
core   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

open access: yesMolecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach   +9 more
wiley   +1 more source

Selection for leukocyte counts in mice

open access: yesGenetical Research, 1966
By directional selection for total leukocyte counts from a hybrid mouse stock we have gradually established two lines of mice, LLC (Low Leukocyte Count) and HLC (High Leukocyte Count), which differ both in total and in differential leukocyte counts. A randombred line (RLC) is also being concurrently maintained.
openaire   +2 more sources

Partial FAK suppression promotes tumor growth, an effect reversed by macrophage p110δ PI3K inactivation

open access: yesMolecular Oncology, EarlyView.
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou   +4 more
wiley   +1 more source

Changes in total and differential leukocyte counts during the clinically silent liver phase in a controlled human malaria infection in malaria-naïve Dutch volunteers

open access: yesMalaria Journal, 2017
Background Both in endemic countries and in imported malaria, changes in total and differential leukocyte count during Plasmodium falciparum infection have been described.
Marlies E. van Wolfswinkel   +7 more
doaj   +1 more source

Effect of anticoagulants on leukocyte count and viability.

open access: yes, 2014
Leukocytes were isolated from sodium-heparin- and EDTA whole blood samples followed by analysis of cell viability and count. Values are represented as mean ± SE of two independent experiments.Effect of anticoagulants on leukocyte count and viability.
Nikolai Siebert (630387)   +4 more
core   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy